Table 3.

Multivariate analysis of the association between the potential gene signatures and gender and pathological tumor staging (p < 0.05).

Variable 1	Odds Ratio	95% CI 2	p-Value
FGFR3_GNA11_H3F3A_IL12A_IL1R1_IL2RB_NKD1_SGK2_SPRY2 (Low vs. High)	25.6	4.71–139.23	0.0002
GENDER (Male vs. Female)	2.26	0.48–10.72	0.3048
PATH_T_TNM (Tis-T0-T1-T2 vs. T3)	0.08	0.02–0.46	0.0042

¹ Abbreviations: PATH, pathological; T, tumor; N, node; M, metastasis. ² CI, confidence interval.